Disturbance of the 3R/4R ratio of MAPT has been evident in neurodegenerative diseases such as Frontotemporal dementia (FTD), Corticobasal degeneration (CBD), Progressive supranuclear palsy (PSP) and AD. This evidence concerns the gene MAPT and neurodegenerative disease.